Global Monoclonal Antibody Custom Service Market Growth (Status and Outlook) 2023-2029

Global Monoclonal Antibody Custom Service Market Growth (Status and Outlook) 2023-2029

Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages.

LPI (LP Information)' newest research report, the “Monoclonal Antibody Custom Service Industry Forecast” looks at past sales and reviews total world Monoclonal Antibody Custom Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibody Custom Service sales for 2023 through 2029. With Monoclonal Antibody Custom Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibody Custom Service industry.

This Insight Report provides a comprehensive analysis of the global Monoclonal Antibody Custom Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibody Custom Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monoclonal Antibody Custom Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibody Custom Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibody Custom Service.

The global Monoclonal Antibody Custom Service market size is projected to grow from US$ 976.9 million in 2022 to US$ 1501 million in 2029; it is expected to grow at a CAGR of 6.3% from 2023 to 2029.

Once monoclonal antibodies for a given substance have been produced, they can be used to detect the presence of this substance. The Western blot test and immuno dot blot tests detect the protein on a membrane. They are also very useful in immunohistochemistry, which detect antigen in fixed tissue sections and immunofluorescence test, which detect the substance in a frozen tissue section or in live cells. Antibodies can also be used to purify their target compounds from mixtures, using the method of immunoprecipitation. In addition, therapeutic monoclonal antibodies act through multiple mechanisms, such as blocking of targeted molecule functions, inducing apoptosis in cells which express the target, or by modulating signalling pathways.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibody Custom Service market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Rat Custom Monoclonal Antibody
Rabbit Custom Monoclonal Antibody
Others

Segmentation by application
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
GenScript
Abnova Corporation
Creative-Biolabs
Abcam
ProMab Biotechnologies
Envigo

Please note: The report will take approximately 2 business days to prepare and deliver.